You are here

  • Home
  • Archive
  • Volume 8, Issue 2
  • SGLT2 inhibitors in patients with type 2 diabetes with non-alcoholic fatty liver diseases: an umbrella review of systematic reviews

Article info

Article menu
XML
Metabolism
SGLT2 inhibitors in patients with type 2 diabetes with non-alcoholic fatty liver diseases: an umbrella review of systematic reviews

Authors

  • Shih-Chieh Shao Department of Pharmacy, Keelung Chang Gung Memorial Hospital, Keelung, TaiwanSchool of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan PubMed articlesGoogle scholar articles
  • Liang-Tseng Kuo Division of Sports Medicine, Department of Orthopaedic Surgery, Chiayi Chang Gung Memorial Hospital, Chiayi, TaiwanCollege of Medicine, Chang Gung University, Taoyuan, Taiwan PubMed articlesGoogle scholar articles
  • Rong-Nan Chien College of Medicine, Chang Gung University, Taoyuan, TaiwanLiver Research Unit, Linkou Chang Gung Memorial Hospital, Taoyuan, TaiwanDivision of Hepatology, Department of Gastroenterology and Hepatology, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan PubMed articlesGoogle scholar articles
  • Ming-Jui Hung College of Medicine, Chang Gung University, Taoyuan, TaiwanSection of Cardiology, Department of Internal Medicine, Keelung Chang Gung Memorial Hospital, Keelung, Taiwan PubMed articlesGoogle scholar articles
  • Edward Chia-Cheng Lai School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, TaiwanDepartment of Pharmacy, National Cheng Kung University Hospital, Tainan, Taiwan PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Edward Chia-Cheng Lai; edward_lai{at}mail.ncku.edu.tw
View Full Text

Citation

Shao S, Kuo L, Chien R, et al
SGLT2 inhibitors in patients with type 2 diabetes with non-alcoholic fatty liver diseases: an umbrella review of systematic reviews
BMJ Open Diabetes Research and Care 2020;8:e001956. doi: 10.1136/bmjdrc-2020-001956

Publication history

  • Received October 20, 2020
  • Revised November 3, 2020
  • Accepted November 6, 2020
  • First published December 2, 2020.
Online issue publication 
January 05, 2021

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.